ACM
ATRS

Ashford Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Ashford Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,088,675
Closed -$2.91M – 134
2014
Q2 		$2.91M Buy
1,088,675
+228,100
+27% +$687K 0.58% 62
2014
Q1 		$3.01M Buy
860,575
+11,425
+1% +$50.7K 0.58% 58
2013
Q4 		$3.8M Buy
849,150
+669,650
+373% +$2.73M 0.72% 48
2013
Q3 		$729K Sell
179,500
-47,100
-21% -$206K 0.15% 96
2013
Q2 		$943K Buy
+226,600
New +$875K 0.2% 89

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Ashford Capital Management's ATRS Position: Q3 2014 in Review

Ashford Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q3 2014, closing a stake of 1,088,675 shares — an estimated $2.91M sold.

Ashford Capital Management first reported a position in ATRS in Q2 2013 and held it in 5 quarters. The position peaked at $3.8M in Q4 2013. 82 funds tracked by Wall St. Rank hold ATRS as of Q3 2014.

  • Ashford Capital Management reported no remaining Antares Pharma, Inc. position as of Q3 2014 after selling out during the quarter.
  • Ashford Capital Management sold 1,088,675 Antares Pharma, Inc. shares in Q3 2014, an estimated $2.91M.
  • Ashford Capital Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 5 quarters.
  • Ashford Capital Management's Antares Pharma, Inc. position peaked at $3.8M in Q4 2013.
  • 82 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2014.

Based on Ashford Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.